--- title: "Weekly Recap | IBM.US +0.58%, quantum milestone lifts sentiment" type: "News" locale: "en" url: "https://longbridge.com/en/news/296668606.md" description: "IBM gained 0.58% this week to close at $235.68, outperforming the S&P 500 by roughly 2.01 percentage points after the benchmark slid 1.43%. The week opened with a sharp sell-off: the stock dropped to an intraweek low of $227.40 on Monday before staging a steady recovery. A midweek rally on Wednesday pushed the price to a session high of $238.72, and the stock eventually settled at $235.68 on Friday. The weekly range was 4.89%, while average daily volume came in at around 5." datetime: "2026-08-22T05:06:38.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/296668606.md) - [en](https://longbridge.com/en/news/296668606.md) - [zh-HK](https://longbridge.com/zh-HK/news/296668606.md) generator: "portal-rs" --- # Weekly Recap | IBM.US +0.58%, quantum milestone lifts sentiment ## The Week IBM gained 0.58% this week to close at $235.68, outperforming the S&P 500 by roughly 2.01 percentage points after the benchmark slid 1.43%. The week opened with a sharp sell-off: the stock dropped to an intraweek low of $227.40 on Monday before staging a steady recovery. A midweek rally on Wednesday pushed the price to a session high of $238.72, and the stock eventually settled at $235.68 on Friday. The weekly range was 4.89%, while average daily volume came in at around 5.3m shares — about 34% below the 60-day median, suggesting a relatively quiet week of trading. ## Key Events Quantum computing dominated the narrative this week. On Wednesday, IBM announced it had connected its first modular cryogenic system, a milestone in the company’s roadmap towards fault-tolerant quantum computing by 2029. The update was well received, and the stock rallied the following day. Separately, the Singapore Institute of Technology and IBM advanced their plan to build a quantum-safe centre in Punggol, with a target launch by end-2026. The facility aims to address post-quantum security risks and strengthen Singapore’s quantum resilience. On the ecosystem front, BrainChip said it would integrate its Akida neuromorphic platform with IBM’s workload management solution, further extending IBM’s AI partnerships. Several institutional investors — including Union Bancaire Privee and Farther Finance Advisors — disclosed increased positions in IBM, though such 13F-type filings typically carry limited price impact. ## Analyst Ratings As of 19 August, 26 analysts cover IBM: 10 rate it buy, 3 rate it overweight, 10 rate it hold, 1 rates it underweight, 1 rates it sell, and 1 has no opinion. The consensus recommendation is ‘buy’, with a consensus target of $244.91 — implying roughly 3.92% upside from the week’s close. The target range is wide, from $174 to $350, pointing to a notable divergence in how analysts value the stock. Within the IT consulting industry, IBM ranks 3rd out of 35 companies, placing it near the top of its peer group. ## The Week Ahead No IBM-specific earnings or major events are on the immediate calendar. Macro data will take centre stage: on Tuesday 25 August, the US consumer confidence index (prior 90.8, forecast 90.1), new home sales, and FHFA house price data are due. A weaker-than-expected confidence reading could weigh on sentiment across tech names. IBM’s Q3 FY2026 results are scheduled for 21 October after the close, with consensus estimates pointing to EPS of $2.489 and revenue of $16.8bn. That print will be the next major checkpoint for the company’s quantum-commercialisation story and its core business momentum. ## In Short IBM managed a gain in a week when the broader market pulled back, with the quantum-computing update acting as a clear sentiment driver. The analyst community leans constructive: the consensus rating is buy, the consensus target sits above the spot price, and the stock ranks highly within its industry. At the same time, the wide target range suggests the market is still debating how to price IBM’s long-term transformation. With a trailing P/E of ~20.7x and a dividend yield of 2.86%, the stock offers a blend of growth narrative and defensive characteristics. The key questions ahead are whether quantum milestones continue to arrive on schedule, and whether October’s earnings can confirm that the core business is delivering. *This article is generated by LongbridgeAI from market data, for information only and not investment advice.* ### Related Stocks - [IBM.US](https://longbridge.com/en/quote/IBM.US.md) ## Related News & Research - [IBM Just Hit a New Quantum Computing Milestone. How to Play IBM Stock Now.](https://longbridge.com/en/news/296817648.md) - [Here Is How to Play IBM Stock After Its Arm and IBM Z Breakthrough](https://longbridge.com/en/news/297080457.md) - [IBM Study: Sports Fans Want Streamlined Digital Experiences as Platform Choices Expand | IBM Stock News](https://longbridge.com/en/news/296733665.md) - [IBM and the USTA Introduce New AI-Powered Fan Experiences for 2026 US Open | IBM Stock News](https://longbridge.com/en/news/296733644.md) - [IBM vs. Microsoft: One Has 58% Upside and Nearly 4x the Yield. The Better Buy May Surprise You.](https://longbridge.com/en/news/296933187.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**